Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform Minovia Therapeutics (Nasdaq: LPAA) announced two new U.S. patents granted on January 13, 2026, strengthening intellectual property for its proprietary Mitochondrial Augmentation Therapy (MAT) platform.U.S. Patent No. 12,502,408 covers MAT for primary mitochondrial diseases and claims the lead program MNV-201 H1 2026 and an eventual Nasdaq listing under a new ticker.

#LPAA Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

www.stocktitan.net/news/LPAA/minovia-therap...

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in Shaare Zedek Medical Center show high safety profile and preliminary efficacy HAIFA, Israel, Nov. 20,

#LPAA Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

www.stocktitan.net/news/LPAA/minovia-therap...

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage

#LPAA Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

www.stocktitan.net/news/LPAA/minovia-therap...

Second FDA Fast Track: Minovia's MNV-201 Advances Against Age-Related Blood Disease MDS FDA grants Fast Track Designation for Minovia's MNV-201 in Myelodysplastic Syndrome. Drug already holds Fast Track status for Pearson Syndrome. Company plans Nasdaq listing via SPAC merger.

#LPAA Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome

www.stocktitan.net/news/LPAA/minovia-therap...

$350K Grant Powers Breakthrough: Minovia Therapeutics to Develop Blood Test for Mitochondrial Health Biotech firm Minovia receives $350K to develop blood-based mitochondrial biomarkers, studying 170 subjects. Research aims to create MitoScore system for measuring mitochondrial function.

#LPAA Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers

www.stocktitan.net/news/LPAA/minovia-therap...

FDA Fast Track Breakthrough: New Hope for Children with Fatal Pearson Syndrome as MNV-201 Advances Minovia's MNV-201 receives dual FDA designations for ultra-rare childhood disease. Learn how Fast Track status accelerates path to potential treatment. See timeline.

#LPAA Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome

www.stocktitan.net/news/LPAA/minovia-therap...

Member of the Order of Canada. We are thrilled to announce that Dr. Aura Kagan, our esteemed colleague, friend, and mentor, has been appointed as a Member of the Order of Canada (C.M.) to celebrate her exceptional contributions to Canadian society and her groundbreaking work in the field of aphasia. Congratulations, Dr. Aura Kagan.

Congratulations to Dr. Aura Kagan! Her work has had a profound impact on Canadians living with aphasia and the SLPs who work with them.
#aphasia #supportedconversation #lifeparticipation #LPAA #acknowledgingcompetence #stroke #ABI #overcomingbarriers #livingwithaphasia #SLPeeps #SLPinspiration

Sitting at Starbucks enjoying a coffee and marking my @fanshawecollege.bsky.social Statistics projects. I love teaching, but man does marking suck. One of the few things I miss about the University world: Teaching Assistants. #ProfLife #ProductivelyKillingTime #TheatreKid #LPAA

.@pwatkinson: "3 priorities for implementation in coming years: action before 2020, bottom up approach through #INDCs and #LPAA." #EDD16

Les solutions du Business seront elles efficaces pour rester sous #1o5C et sauver l'humanité? #LPAA #keepintheground

Besoin des critères claires pour faire face aux fausses solutions agricoles et respecter les droits humains #COP21 #LPAA @coordinationsud